The Discovery of Heparin
1959; Lippincott Williams & Wilkins; Volume: 19; Issue: 1 Linguagem: Inglês
10.1161/01.cir.19.1.75
ISSN1524-4539
Autores Tópico(s)Biochemical and Structural Characterization
ResumoHomeCirculationVol. 19, No. 1The Discovery of Heparin Free AccessResearch ArticlePDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBThe Discovery of Heparin JAY MCLEAN JAY MCLEANJAY MCLEAN Originally published1 Jan 1959https://doi.org/10.1161/01.CIR.19.1.75Circulation. 1959;19:75–78 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Kondashevskaya M (2022) Horizons of Heparin Therapy in COVID-19 and Pandemic-Related Diseases, Journal of Evolutionary Biochemistry and Physiology, 10.1134/S002209302202020X, 58:2, (523-534), Online publication date: 1-Mar-2022. Holman W, Timpa J and Kirklin J (2022) Origins and Evolution of Extracorporeal Circulation, Journal of the American College of Cardiology, 10.1016/j.jacc.2022.02.027, 79:16, (1606-1622), Online publication date: 1-Apr-2022. Chen L, Zhu W, Yan N, Guo Y, Yi L, Ouyang Y and Zhang Z (2022) Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS, Journal of Pharmaceutical and Biomedical Analysis, 10.1016/j.jpba.2022.114616, 212, (114616), Online publication date: 1-Apr-2022. Puzari U, Fernandes P and Mukherjee A (2021) Advances in the Therapeutic Application of Small-Molecule Inhibitors and Repurposed Drugs against Snakebite, Journal of Medicinal Chemistry, 10.1021/acs.jmedchem.1c00266, 64:19, (13938-13979), Online publication date: 14-Oct-2021. Dalton H and Desai M (2021) ECMO from Conception to Execution Comprehensive Healthcare Simulation: ECMO Simulation, 10.1007/978-3-030-53844-6_1, (3-9), . Giri S, Dutta P, Kumarasamy D and Giri T (2021) Natural polysaccharides: Types, basic structure and suitability for forming hydrogels Plant and Algal Hydrogels for Drug Delivery and Regenerative Medicine, 10.1016/B978-0-12-821649-1.00007-6, (1-35), . Kruger E, Ben-Amotz O, Mendenhall S, Kovach S and Levin L (2021) Microsurgical Reconstruction of the Mangled Limb The Mangled Extremity, 10.1007/978-3-319-56648-1_8, (103-119), . Zhu C, Xu Z, Yuan Y, Wang T, Xu C, Yin C, Xie P, Xu P, Ye H, Patel N, Schaul S, Wang L, Zhu X, Wang S, Gao P, Xi Q, Zhang Y, Shu G and Jiang Q (2021) Heparin impairs skeletal muscle glucose uptake by inhibiting insulin binding to insulin receptor, Endocrinology, Diabetes & Metabolism, 10.1002/edm2.253, 4:3, Online publication date: 1-Jul-2021. Khalifa S, Yosri N, El-Mallah M, Ghonaim R, Guo Z, Musharraf S, Du M, Khatib A, Xiao J, Saeed A, El-Seedi H, Zhao C, Efferth T and El-Seedi H (2021) Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic, Phytomedicine, 10.1016/j.phymed.2020.153311, 85, (153311), Online publication date: 1-May-2021. Chen L, Ouyang Y, Yan N, Guo Y, Yi L, Sun Y, Liu D and Zhang Z (2021) Comprehensive analysis of heparinase derived heparin-products using two-dimensional liquid chromatography coupled with mass spectrometry, Journal of Chromatography A, 10.1016/j.chroma.2021.462049, 1643, (462049), Online publication date: 1-Apr-2021. Santos G, Martins L, Bregadiolli B, Moreno V, Silva‐Filho L and Silva B (2021) Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications, Journal of Heterocyclic Chemistry, 10.1002/jhet.4349, 58:12, (2226-2260), Online publication date: 1-Dec-2021. Green D (2020) Introduction The Heparins, 10.1016/B978-0-12-818781-4.00009-1, (xiii-xvii), . Barra M, Roberts R and Rosovsky R (2020) Treatment for Pulmonary Embolism: Anticoagulation Selection and Duration Pulmonary Embolism, 10.1007/978-3-030-51736-6_5, (57-83), . Spadarella G, Di Minno A, Donati M, Mormile M, Ventre I and Di Minno G (2020) From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation, Blood Reviews, 10.1016/j.blre.2019.100613, 39, (100613), Online publication date: 1-Jan-2020. Carrier M, Soff G and Le Gal G (2019) Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants Thrombosis and Hemostasis in Cancer, 10.1007/978-3-030-20315-3_7, (103-115), . Mazzeffi M and Lowery A (2019) Anticoagulation Options Coronary and Cardiothoracic Critical Care, 10.4018/978-1-5225-8185-7.ch022, (474-498) Dieter R, Singh S, Chawla J, Drake D, Pacanowski J and Dieter R (2019) A Timeline History of Aortic Disease and Therapies, Including Surgery Diseases of the Aorta, 10.1007/978-3-030-11322-3_1, (1-8), . Ong C, Marcum J, Zehr K and Cameron D (2019) A Century of Heparin, The Annals of Thoracic Surgery, 10.1016/j.athoracsur.2019.03.104, 108:3, (955-958), Online publication date: 1-Sep-2019. Caputo H, Straub J and Grinstaff M (2019) Design, synthesis, and biomedical applications of synthetic sulphated polysaccharides, Chemical Society Reviews, 10.1039/C7CS00593H, 48:8, (2338-2365) Lee T and Torregrossa G (2018) Total Artificial Heart Encyclopedia of Cardiovascular Research and Medicine, 10.1016/B978-0-12-809657-4.99668-6, (545-557), . Torregrossa G (2018) OBSOLETE: Total Artificial Heart Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.99668-5, . Yi L, Zhang Q, Meng Y, Hao J, Xie B, Gan H, Li D, Dong K and Zhang Z (2018) Qualitative and quantitative analysis of 2, 5-anhydro-d-mannitol in low molecular weight heparins with high performance anion exchange chromatography hyphenated quadrupole time of flight mass spectrometry, Journal of Chromatography A, 10.1016/j.chroma.2018.07.058, 1569, (160-167), Online publication date: 1-Sep-2018. Byvaltsev V, Akshulakov S, Polkin R, Ochkal S, Stepanov I, Makhambetov Y, Kerimbayev T, Staren M, Belykh E and Preul M (2018) Microvascular Anastomosis Training in Neurosurgery: A Review, Minimally Invasive Surgery, 10.1155/2018/6130286, 2018, (1-9), . Bolten S, Rinas U and Scheper T (2018) Heparin: role in protein purification and substitution with animal-component free material, Applied Microbiology and Biotechnology, 10.1007/s00253-018-9263-3, 102:20, (8647-8660), Online publication date: 1-Oct-2018. Fasano A and Sequeira A (2017) Blood Coagulation Hemomath, 10.1007/978-3-319-60513-5_2, (79-158), . Poterucha T, Libby P and Goldhaber S (2017) More than an anticoagulant: Do heparins have direct anti-inflammatory effects?, Thrombosis and Haemostasis, 10.1160/TH16-08-0620, 117:03, (437-444), . McFadden P, Wiggins L and Boys J (2017) A History of Thoracic Aortic Surgery, Cardiology Clinics, 10.1016/j.ccl.2017.03.001, 35:3, (307-316), Online publication date: 1-Aug-2017. Rosovsky R and Merli G (2017) Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants, Techniques in Vascular and Interventional Radiology, 10.1053/j.tvir.2017.07.003, 20:3, (141-151), Online publication date: 1-Sep-2017. Zhu C, Xu P, He Y, Yuan Y, Wang T, Cai X, Yu L, Yang L, Wu J, Wang L, Zhu X, Wang S, Gao P, Xi Q, Zhang Y, Xu Y, Jiang Q and Shu G (2017) Heparin Increases Food Intake through AgRP Neurons, Cell Reports, 10.1016/j.celrep.2017.08.049, 20:10, (2455-2467), Online publication date: 1-Sep-2017. Taylor R (2017) Medical Authorisms and Their Creators The Amazing Language of Medicine, 10.1007/978-3-319-50328-8_8, (149-171), . Weiss R, Esko J and Tor Y (2017) Targeting heparin and heparan sulfate protein interactions, Organic & Biomolecular Chemistry, 10.1039/C7OB01058C, 15:27, (5656-5668) Lozano Sánchez F and Areitio-Aurtena Bolumburu D (2017) Jay McLean, 100 años de heparina, Angiología, 10.1016/j.angio.2016.05.005, 69:5, (332-333), Online publication date: 1-Sep-2017. Hedner U (2017) The First Years at Novo Nordisk Treating Life-Threatening Bleedings, 10.1016/B978-0-12-812439-0.00003-4, (27-36), . Harenberg J (2016) Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal function, International Journal of Cardiology, 10.1016/S0167-5273(16)12003-0, 212, (S10-S13), Online publication date: 1-Jun-2016. Bijak M, Saluk J, Szelenberger R and Nowak P (2016) Popular naturally occurring antioxidants as potential anticoagulant drugs, Chemico-Biological Interactions, 10.1016/j.cbi.2016.07.022, 257, (35-45), Online publication date: 1-Sep-2016. Riffo-Vasquez Y, Somani A, Man F, Amison R, Pitchford S and Page C (2016) A Non-Anticoagulant Fraction of Heparin Inhibits Leukocyte Diapedesis into the Lung by an Effect on Platelets, American Journal of Respiratory Cell and Molecular Biology, 10.1165/rcmb.2015-0172OC, 55:4, (554-563), Online publication date: 1-Oct-2016. Widimský P (2016) Is bivalirudin just an expensive heparin?: Table 1, European Heart Journal, 10.1093/eurheartj/ehw031, 37:16, (1321-1324), Online publication date: 21-Apr-2016. Chandarajoti K, Liu J and Pawlinski R (2016) The design and synthesis of new synthetic low-molecular-weight heparins, Journal of Thrombosis and Haemostasis, 10.1111/jth.13312, 14:6, (1135-1145), Online publication date: 1-Jun-2016. Bhatt M, Paes B and Chan A (2016) How to use unfractionated heparin to treat neonatal thrombosis in clinical practice, Blood Coagulation & Fibrinolysis, 10.1097/MBC.0000000000000469, 27:6, (605-614), Online publication date: 1-Sep-2016. Haas S (2017) The long path to NOAC, Phlebologie, 10.12687/phleb2319-4-2016, 45:04, (245-251), Online publication date: 1-Jul-2016. Coller B (2015) Blood at 70: its roots in the history of hematology and its birth, Blood, 10.1182/blood-2015-09-659581, 126:24, (2548-2560), Online publication date: 10-Dec-2015. Mazzeffi M and Lowery A Anticoagulation Options Modern Concepts and Practices in Cardiothoracic Critical Care, 10.4018/978-1-4666-8603-8.ch011, (253-277) Patel N, Alejo D and Cameron D (2015) The History of Heart Surgery at The Johns Hopkins Hospital, Seminars in Thoracic and Cardiovascular Surgery, 10.1053/j.semtcvs.2015.11.001, 27:4, (341-352), Online publication date: 1-Dec-2016. Qi P, Chen S, Liu T, Chen J, Yang Z, Weng Y, Chen J, Wang J, Maitz M and Huang N (2014) New strategies for developing cardiovascular stent surfaces with novel functions (Review), Biointerphases, 10.1116/1.4878719, 9:2, (029017), Online publication date: 1-Jun-2014. Fareed J, Kalodiki E and Hoppensteadt D (2014) Management of Thrombotic Disorders Urgent Interventional Therapies, 10.1002/9781118504499.ch4, (27-40) Haug M (2018) Curious stories surrounding the discovery and development of conventional antithrombotics, Phlebologie, 10.12687/phleb2179-2-2014, 43:02, (93-98), Online publication date: 1-Mar-2014. Bodnár T, Fasano A and Sequeira A (2014) Mathematical Models for Blood Coagulation Fluid-Structure Interaction and Biomedical Applications, 10.1007/978-3-0348-0822-4_7, (483-569), . Shastri M, Johns C, Hutchinson J, Khandagale M and Patel R (2013) Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties, Analytical and Bioanalytical Chemistry, 10.1007/s00216-013-6996-9, 405:18, (6043-6052), Online publication date: 1-Jul-2013. WANG Z (2013) The blossom of "the rose of surgery" — The birth of heart-lung machine, Journal of Medical Colleges of PLA, 10.1016/S1000-1948(13)60010-6, 28:1, (11-19), Online publication date: 1-Feb-2013. Galanaud J, Laroche J and Righini M (2013) The history and historical treatments of deep vein thrombosis, Journal of Thrombosis and Haemostasis, 10.1111/jth.12127, 11:3, (402-411), Online publication date: 1-Mar-2013. Perez A and Merli G (2013) Novel Anticoagulant Use for Venous Thromboembolism: A 2013 Update, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-013-0230-0, 15:2, (164-172), Online publication date: 1-Apr-2013. Pascarella L, Cox M and O'Brien P (2015) Venous Thromboembolism: Diagnosis and Current Anticoagulation Strategies for Deep Vein Thrombosis and Pulmonary Embolism, Hospital Practice, 10.3810/hp.2012.08.990, 40:3, (58-70), Online publication date: 1-Aug-2012. Zehnder J, Price E and Jin J (2012) Controversies in heparin monitoring, American Journal of Hematology, 10.1002/ajh.23210, 87:S1, (S137-S140), Online publication date: 1-May-2012. McGann C and Kiick K (2012) Heparin-Functionalized Materials in Tissue Engineering Applications Engineering Biomaterials for Regenerative Medicine, 10.1007/978-1-4614-1080-5_9, (225-250), . (2012) CardioPulse Articles, European Heart Journal, 10.1093/eurheartj/ehs364, 33:23, (2883-2891), Online publication date: 1-Dec-2012., Online publication date: 1-Dec-2012. Barrowcliffe T (2012) History of Heparin Heparin - A Century of Progress, 10.1007/978-3-642-23056-1_1, (3-22), . Apostolakis S, Lip G, Lane D and Shantsila E (2010) The Quest for New Anticoagulants: From Clinical Development to Clinical Practice, Cardiovascular Therapeutics, 10.1111/j.1755-5922.2010.00160.x, 29:6, (e12-e22), Online publication date: 1-Dec-2011. Spiess B, Horrow J and Kaplan J (2011) Transfusion Medicine and Coagulation Disorders Kaplan's Cardiac Anesthesia: The Echo Era, 10.1016/B978-1-4377-1617-7.00037-6, (949-991), . (2010) Meeting the Unmet Needs in Anticoagulant Therapy, European Journal of Haematology, 10.1111/j.1600-0609.2010.01461.x, 85, (1-28) Helton T and Kapadia S (2010) Antithrombotic Therapy in Carotid and Peripheral Intervention Antithrombotic Drug Therapy in Cardiovascular Disease, 10.1007/978-1-60327-235-3_15, (283-305), . (2009) Commercializing Research Discoveries Pursuing Excellence in Healthcare, 10.1201/9781439816608-13, (147-162) Pawlaczyk I, Czerchawski L, Pilecki W, Lamer-Zarawska E and Gancarz R (2009) Polyphenolic-polysaccharide compounds from selected medicinal plants of Asteraceae and Rosaceae families: Chemical characterization and blood anticoagulant activity, Carbohydrate Polymers, 10.1016/j.carbpol.2009.01.030, 77:3, (568-575), Online publication date: 1-Jul-2009. Khoynezhad A, Celis R, Hashemzadeh M, Movahed M and Jalali Z (2009) Current status of thoracic endografting and its adjunctive pharmacology, Expert Opinion on Pharmacotherapy, 10.1517/14656560903277194, 10:17, (2871-2881), Online publication date: 1-Dec-2009. (2009) Commercializing Research Discoveries Pursuing Excellence in Healthcare, 10.1201/9781439816608.ch6, (109-124), Online publication date: 3-Sep-2009. (2009) Historical Background Transcatheter Valve Therapies, 10.3109/9781439810828-3, (4-27), Online publication date: 25-Sep-2009. Stringer M and Ahmadi O Famous discoveries by medical students, ANZ Journal of Surgery, 10.1111/j.1445-2197.2009.05142.x, 79:12, (901-908) Copeland C and Six C (2009) A Tale of Two Anticoagulants: Warfarin and Heparin, Journal of Surgical Education, 10.1016/j.jsurg.2009.03.035, 66:3, (176-181), Online publication date: 1-May-2009. Kirwan C and Frankel A (2009) The Artificial Kidney Artificial Organs, 10.1007/978-1-84882-283-2_3, (39-55), . Coscas R, Boura B, Koskas F, Julia P and Fabiani J (2009) Ischémie aiguë de membre, EMC - Angéiologie, 10.1016/S1290-0176(09)71330-4, 4:1, (1-20), Online publication date: 1-Jan-2009. Dave S and Park M (2008) Successful Heparin Desensitization: A Case Report and Review of the Literature, Journal of Cardiac Surgery, 10.1111/j.1540-8191.2008.00583.x, 23:4, (394-397), Online publication date: 1-Jul-2008. Gortler D, Schlösser F, Muhs B, Nelson M and Dardik† A (2008) Periprocedural Drug Therapy in Carotid Artery Stenting: The Need for More Evidence, Vascular, 10.2310/6670.2008.00081, 16:6, (303-309), Online publication date: 1-Dec-2008. Yin D, Yao W and Gao X (2007) Chemically Modified Heparin Inhibits Mesangial Cell Proliferation Induced by High Glucose through Interfering with the Cell Cycle, Biological and Pharmaceutical Bulletin, 10.1248/bpb.30.2274, 30:12, (2274-2278), . Gortler D, Maloney S, Rutland R, Westvik T, Muto A, Kudo F and Dardik A (2016) Adjunctive Pharmacologic Use in Carotid Endarterectomy: A Review, Vascular, 10.2310/6670.2006.00020, 14:2, (93-102), Online publication date: 1-Apr-2006. Brown R, Lever R, Jones N and Page C (2009) Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro , British Journal of Pharmacology, 10.1038/sj.bjp.0705291, 139:4, (845-853), Online publication date: 1-Jun-2003. Caballero M and Fernández-Benítez M (2003) Allergy to heparin: A new in vitro diagnostic technique, Allergologia et Immunopathologia, 10.1016/S0301-0546(03)79206-4, 31:6, (324-328), Online publication date: 1-Jan-2003. Mentzer R, Mulford C and Lasley R (2001) Research in Cardiac Surgery Surgical Research, 10.1016/B978-012655330-7/50082-4, (1119-1136), . Chaubet F, Chevolot L, Jozefonvicz J, Durand P and Boisson-Vidal C (2000) Relationships between chemical characteristics and anticoagulant activity of low molecular weight fucans from marine algae Bioactive Carbohydrate Polymers, 10.1007/978-94-015-9572-8_6, (59-84), . (2000) Bibliography Articles Cited in Commentaries Hematology, 10.1016/B978-012448510-5.50184-9, (1023-1058), . Mutt V and Blombäck M (2000) Chapter 7 Erik Jorpes — a pragmatic physiological chemist Selected Topics in the History of Biochemistry Personal Recollections. VI, 10.1016/S0069-8032(00)41011-9, (363-389), . Bell W and Hennebry T (1999) Heparin and Other Indirect Antithrombin Agents Antithrombotics, 10.1007/978-3-642-59942-2_9, (259-303), . Klokkevold P, Fukayama H, Sung E and Bertolami C (1999) The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits, Journal of Oral and Maxillofacial Surgery, 10.1016/S0278-2391(99)90632-8, 57:1, (49-52), Online publication date: 1-Jan-1999. Kallás I, Kallás A and Kallás E (1999) Anastomoses arteriais: passado, presente e futuro, Acta Cirurgica Brasileira, 10.1590/S0102-86501999000400013, 14:4, (221-227), Online publication date: 1-Oct-1999. Tyrrell D, Horne A, Holme K, Preuss J and Page C (1999) Heparin in Inflammation: Potential Therapeutic Applications beyond Anticoagulation , 10.1016/S1054-3589(08)60471-8, (151-208), . GEORGE C (1998) Hirudin, heparin and Heinrich Necheles, Nephrology, 10.1111/j.1440-1797.1998.tb00351.x, 4:4, (225-228), Online publication date: 1-Aug-1998. Mahoney C (2016) Heparin-bonded circuits: clinical outcomes and costs, Perfusion, 10.1177/026765919801300307, 13:3, (192-204), Online publication date: 1-May-1998. Hagiwara K, Takahashi M, Ichikawa T, Tsuji M, Ikuta K and Ishihara C (1997) Inhibitory effect of heparin on red blood cell invasion by Theileria sergenti merozoites, International Journal for Parasitology, 10.1016/S0020-7519(97)00031-3, 27:5, (535-539), Online publication date: 1-May-1997. Batra M, Adolph M, Thornton J, Byramjee A, Oliver A and Schreiber H (2016) Antithrombin III Deficiency and White Clot Syndrome, Vascular Surgery, 10.1177/153857449603000107, 30:1, (37-44), Online publication date: 1-Jan-1996. Bowlby H, Hisle K and Clifton G (1995) Heparin as adjunctive therapy to coronary thrombolysis in acute myocardial infarction, Heart & Lung, 10.1016/S0147-9563(05)80072-X, 24:4, (292-304), Online publication date: 1-Jul-1995. DeWeese J (1994) Treatment of venous disease – The innovators, Journal of Vascular Surgery, 10.1016/S0741-5214(94)70153-9, 20:5, (675-683), Online publication date: 1-Nov-1994. Mueller R and Scheidt S (1994) History of drugs for thrombotic disease. Discovery, development, and directions for the future., Circulation, 89:1, (432-449), Online publication date: 1-Jan-1994. Penner J (1993) Managing the Hemorrhagic Complications of Heparin Therapy, Hematology/Oncology Clinics of North America, 10.1016/S0889-8588(18)30208-9, 7:6, (1281-1289), Online publication date: 1-Dec-1993. Freedman M (2013) Pharmacodynamics, Clinical Indications, and Adverse Effects of Heparin, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1992.tb05765.x, 32:7, (584-596), Online publication date: 1-Jul-1992. Petitou M and van Boeckel C (1992) Chemical Synthesis of Heparin Fragments and Analogues Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products, 10.1007/978-3-7091-9225-2_2, (143-210), . Freedman M (2013) Low Molecular Weight Heparins: An Emerging New Class of Glycosaminoglycan Antithrombotics, The Journal of Clinical Pharmacology, 10.1002/j.1552-4604.1991.tb03709.x, 31:4, (298-306), Online publication date: 1-Apr-1991. Baird R (1990) Presidential address: "Give us the tools...", Journal of Vascular Surgery, 10.1016/0741-5214(90)90323-3, 11:1, (4-18), Online publication date: 1-Jan-1990. Sinard J and Bartlett R (2016) Review articles : Extracorporeal membrane oxygenation (ECMO): prolonged bedside cardiopulmonary bypass, Perfusion, 10.1177/026765919000500402, 5:4, (239-249), Online publication date: 1-Oct-1990. Kadish S, Lazar E and Frishman W (1987) Anticoagulation in Patients with Valvular Heart Disease, Atrial Fibrillation, or Both, Cardiology Clinics, 10.1016/S0733-8651(18)30517-4, 5:4, (591-628), Online publication date: 1-Nov-1987. BÖTTIGER L (2009) The Heparin Story, Acta Medica Scandinavica, 10.1111/j.0954-6820.1987.tb10660.x, 222:3, (195-200) Ekre H, Fjellner B and Hägermark Ö (1986) Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions, International Journal of Immunopharmacology, 10.1016/0192-0561(86)90109-8, 8:3, (277-286), Online publication date: 1-Jan-1986. Erke H (1985) Inhibition of human and guinea pig complement by heparin fractions differing in affinity for antithrombin III or in average molecular weight, International Journal of Immunopharmacology, 10.1016/0192-0561(85)90036-0, 7:2, (271-280), Online publication date: 1-Jan-1985. Bell W and Bartholomew J (1985) Pulmonary thromboembolic disease, Current Problems in Cardiology, 10.1016/0146-2806(85)90031-3, 10:9, (1-69), Online publication date: 1-Sep-1985. Fye W (1984) Heparin: the contributions of William Henry Howell., Circulation, 69:6, (1198-1203), Online publication date: 1-Jun-1984. Brewer L (1981) Open heart surgery and myocardial revascularization, The American Journal of Surgery, 10.1016/0002-9610(81)90066-0, 141:6, (618-631), Online publication date: 1-Jun-1981. HOLMER E (2009) ANTICOAGULANT PROPERTIES OF HEPARIN AND HEPARIN FRACTIONS, Scandinavian Journal of Haematology, 10.1111/j.1600-0609.1980.tb02511.x, 24:S36, (25-39) Bartlett R and Gazzaniga A (1978) Extracorporeal circulation for cardiopulmonary failure, Current Problems in Surgery, 10.1016/S0011-3840(78)80008-2, 15:5, (1-96), Online publication date: 1-May-1978. Wukasch D, Cooley D, Reul G, Hall R, Vucinic M, Sandiford F, Korman J, Kyger E and Hallman G (2016) Surgical Treatment of Angina Pectoris: Current Status, Angiology, 10.1177/000331977702800305, 28:3, (169-180), Online publication date: 1-Mar-1977. Koch G and Kraft-Kinz J (1971) Die chirurgische Therapie und ihre Ergebnisse bei obliterierenden Arterienerkrankungen, European Surgery, 10.1007/BF02601182, 3:3, (106-108), Online publication date: 1-May-1971. Little J, Bailey I, Kronenberg H and Halliday J (1970) CIRCULATING HEPARIN-LIKE SUBSTANCE FOLLOWING LIVER INJURY, The Lancet, 10.1016/S0140-6736(70)91182-7, 295:7655, (1055-1056), Online publication date: 1-May-1970. Jorpes J (2006) THE EARLY HISTORY OF HEPARIN, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1964.tb41069.x, 115:1, (392-398) Jorpes J (1964) THE EARLY HISTORY OF HEPARIN, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1964.tb50688.x, 115:2 Computers in, (392-398), Online publication date: 1-Jul-1964. Alexander B (1962) Anticoagulant therapy with coumarin congeners, The American Journal of Medicine, 10.1016/0002-9343(62)90246-2, 33:5, (679-691), Online publication date: 1-Nov-1962. Symbas P, Scott H and Diveley W (1961) EXPERIMENTAL STUDIES OF INTRAPLEURAL INJECTION OF SODIUM HEPARIN IN PNEUMONECTOMIZED DOGS WITH AND WITHOUT INFECTION, The Journal of Thoracic and Cardiovascular Surgery, 10.1016/S0022-5223(20)31907-3, 42:2, (213-218), Online publication date: 1-Aug-1961. Moser K (1960) Use of anticoagulant and fibrinolytic agents, Disease-a-Month, 10.1016/S0011-5029(60)80012-0, 6:3, (1-44), Online publication date: 1-Mar-1960. Dmochowska B, Ślusarz R, Chojnacki J, Samaszko-Fiertek J and Madaj J (2020) The Quaternization Reaction of 5-O-Sulfonates of Methyl 2,3-o-Isopropylidene-β-D-Ribofuranoside with Selected Heterocyclic and Aliphatic Amines, Molecules, 10.3390/molecules25092161, 25:9, (2161) Sahu K, Jindal V, Anderson J, Siddiqui A and Jaiyesimi I (2020) Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia, Journal of Blood Medicine, 10.2147/JBM.S232648, Volume 11, (267-277) Shastri M, Stewart N, Eapen M, Peterson G, Zaidi S, Gueven N, Sohal S, Patel R and Proost P (2015) Opposing Effects of Low Molecular Weight Heparins on the Release of Inflammatory Cytokines from Peripheral Blood Mononuclear Cells of Asthmatics, PLOS ONE, 10.1371/journal.pone.0118798, 10:3, (e0118798) Tüysüz M and Gül A (2020) Mersin'de Tip 1 Aort Diseksiyonunda doku yapıştırıcısı kullanımının kanama üzerine etkisi: Kanama kontrolünün tarihsel kısa analizi, Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi, 10.31020/mutftd.652438 Oduah E, Linhardt R and Sharfstein S (2016) Heparin: Past, Present, and Future, Pharmaceuticals, 10.3390/ph9030038, 9:3, (38) Derbalah A, Duffull S, Newall F, Moynihan K and Al-Sallami H (2019) Revisiting the Pharmacology of Unfractionated Heparin, Clinical Pharmacokinetics, 10.1007/s40262-019-00751-7 January 1, 1959Vol 19, Issue 1 Advertisement Article InformationMetrics © 1959 American Heart Association, Inc.https://doi.org/10.1161/01.CIR.19.1.75 Originally publishedJanuary 1, 1959 PDF download Advertisement
Referência(s)